HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.30
-1.00 (-1.35%)
Jul 4, 2025, 1:44 PM CST
-1.48%
Market Cap 3.37B
Revenue (ttm) 286.42M
Net Income (ttm) 147.22M
Shares Out 46.00M
EPS (ttm) 3.20
PE Ratio 22.91
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,170
Average Volume 140,864
Open 74.30
Previous Close 74.30
Day's Range 72.80 - 74.30
52-Week Range 63.10 - 91.30
Beta n/a
RSI 50.96
Earnings Date Aug 13, 2025

About HeXun Biosciences

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 45
Stock Exchange Taipei Exchange
Ticker Symbol 6986
Full Company Profile

Financial Performance

In 2024, HeXun Biosciences's revenue was 286.42 million, an increase of 119.36% compared to the previous year's 130.57 million. Earnings were 147.22 million, an increase of 339.62%.

Financial Statements

News

There is no news available yet.